Now showing items 1-2 of 2

    • Adjuvant Dendritic Cell Vaccination in High-Risk Uveal Melanoma. 

      Bol, KF; van den Bosch, T; Schreibelt, G; Mensink, HW; Keunen, JEE; Kiliç, E; Japing, WJ; Geul, KW; Westdorp, H; Boudewijns, S; Croockewit, SAJ; van Rossum, MM; de Goede, AL; Naus, NC; van der Graaf, WTA; Gerritsen, WR; de Klein, A; Punt, CJA; Figdor, CG; Cohen, VM; Paridaens, D; de Vries, IJM (2016-10)
    • Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network. 

      Ludwig, H; Boccadoro, M; Moreau, P; San-Miguel, J; Cavo, M; Pawlyn, C; Zweegman, S; Facon, T; Driessen, C; Hajek, R; Dimopoulos, MA; Gay, F; Avet-Loiseau, H; Terpos, E; Zojer, N; Mohty, M; Mateos, M-V; Einsele, H; Delforge, M; Caers, J; Weisel, K; Jackson, G; Garderet, L; Engelhardt, M; van de Donk, N; Leleu, X; Goldschmidt, H; Beksac, M; Nijhof, I; Abildgaard, N; Bringhen, S; Sonneveld, P (2021-01)
      Vaccination is one of the most successful medical interventions that has saved the life of millions of people. Vaccination is particularly important in patients with multiple myeloma, who have an increased risk of infections ...